Difference between revisions of "Envelope glycoprotein gp41"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 50: | Line 50: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:35, 10 March 2015
| Envelope glycoprotein gp41 | |
|---|---|
| Substrate peptide name | Envelope glycoprotein gp41 |
| Synonyms | gp41 |
| Determination type | In vitro |
| Source | HIV |
| Subcellular localization | HIV exterior membrane |
| Swissprot ID | P03378 |
| Reactive glutamines | Q51, Q52, Q66 |
| Reactive lysines | K77 |
| Substrate sequence | RAIEAQQHLLQL
GIKQLQARILA VERYLKDQQLL |
| Structure | 1F23 |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:7688299 |
| Notes | |
